114 related articles for article (PubMed ID: 31005794)
1. High expression of HMBOX1 contributes to poor prognosis of gastric cancer by promoting cell proliferation and migration.
Diao N; Li Y; Yang J; Jin C; Meng X; Jiao W; Feng J; Liu Z; Lu N
Biomed Pharmacother; 2019 Jul; 115():108867. PubMed ID: 31005794
[TBL] [Abstract][Full Text] [Related]
2. Low expression level of HMBOX1 in high-grade serous ovarian cancer accelerates cell proliferation by inhibiting cell apoptosis.
Yu YL; Diao NN; Li YZ; Meng XH; Jiao WL; Feng JB; Liu ZP; Lu N
Biochem Biophys Res Commun; 2018 Jun; 501(2):380-386. PubMed ID: 29709478
[TBL] [Abstract][Full Text] [Related]
3. Homeobox containing 1 inhibits liver cancer progression by promoting autophagy as well as inhibiting stemness and immune escape.
Zhao H; Jia H; Han Q; Zhang J
Oncol Rep; 2018 Sep; 40(3):1657-1665. PubMed ID: 30015890
[TBL] [Abstract][Full Text] [Related]
4. Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers.
Kim TM; Ko YH; Ha SJ; Lee HH
BMC Cancer; 2019 Feb; 19(1):119. PubMed ID: 30717708
[TBL] [Abstract][Full Text] [Related]
5. PROX1 Is Associated with Cancer Progression and Prognosis in Gastric Cancer.
Ueta K; Otowa Y; Kakeji Y; Hirashima M
Anticancer Res; 2018 Nov; 38(11):6139-6145. PubMed ID: 30396930
[TBL] [Abstract][Full Text] [Related]
6. Notch1 directly induced CD133 expression in human diffuse type gastric cancers.
Konishi H; Asano N; Imatani A; Kimura O; Kondo Y; Jin X; Kanno T; Hatta W; Ara N; Asanuma K; Koike T; Shimosegawa T
Oncotarget; 2016 Aug; 7(35):56598-56607. PubMed ID: 27489358
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of SPAG9 in human gastric cancer is correlated with poor prognosis.
Miao ZF; Wang ZN; Zhao TT; Xu YY; Wu JH; Liu XY; Xu H; You Y; Xu HM
Virchows Arch; 2015 Nov; 467(5):525-33. PubMed ID: 26293216
[TBL] [Abstract][Full Text] [Related]
9. Homeobox‑containing protein 1 loss is associated with clinicopathological performance in glioma.
Zhang P; Liu Q; Yan S; Yuan G; Shen J; Li G
Mol Med Rep; 2017 Oct; 16(4):4101-4106. PubMed ID: 28731165
[TBL] [Abstract][Full Text] [Related]
10. Prospero homeobox 1 mediates the progression of gastric cancer by inducing tumor cell proliferation and lymphangiogenesis.
Park KJ; Cho SB; Park YL; Kim N; Park SY; Myung DS; Lee WS; Kweon SS; Joo YE
Gastric Cancer; 2017 Jan; 20(1):104-115. PubMed ID: 26759228
[TBL] [Abstract][Full Text] [Related]
11. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.
Yuan C; Zhu X; Han Y; Song C; Liu C; Lu S; Zhang M; Yu F; Peng Z; Zhou C
J Exp Clin Cancer Res; 2016 Jan; 35():15. PubMed ID: 26791264
[TBL] [Abstract][Full Text] [Related]
12. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.
He X; Liu Z; Xia Y; Xu J; Lv G; Wang L; Ma T; Jiang L; Mou Y; Jiang X; Ma J; Zhao Z; Ni H; Xu W; Ru G; Huang D; Tao H
Oncotarget; 2017 Jan; 8(1):1247-1261. PubMed ID: 27901487
[TBL] [Abstract][Full Text] [Related]
13. Co-Expression of LGR5 and CD133 Cancer Stem Cell Predicts a Poor Prognosis in Patients With Gastric Cancer.
Wattanawongdon W; Bathpho TS; Tongtawee T
Turk J Gastroenterol; 2021 Mar; 32(3):261-268. PubMed ID: 34160355
[TBL] [Abstract][Full Text] [Related]
14. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
[TBL] [Abstract][Full Text] [Related]
15. SMURF1 promotes the proliferation, migration and invasion of gastric cancer cells.
Tao Y; Sun C; Zhang T; Song Y
Oncol Rep; 2017 Sep; 38(3):1806-1814. PubMed ID: 28731194
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
[TBL] [Abstract][Full Text] [Related]
17. CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis.
Yiming L; Yunshan G; Bo M; Yu Z; Tao W; Gengfang L; Dexian F; Shiqian C; Jianli J; Juan T; Zhinan C
Oncotarget; 2015 Dec; 6(39):42019-27. PubMed ID: 26503471
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Tumor Progression Associated With CD133 Overexpression: Involvement of Increased TERT Expression and Epidermal Growth Factor Receptor-Dependent Akt Activation.
Weng CC; Kuo KK; Su HT; Hsiao PJ; Chen YW; Wu DC; Hung WC; Cheng KH
Pancreas; 2016 Mar; 45(3):443-57. PubMed ID: 26646272
[TBL] [Abstract][Full Text] [Related]
19. HOXC10 overexpression promotes cell proliferation and migration in gastric cancer.
Kim J; Bae DH; Kim JH; Song KS; Kim YS; Kim SY
Oncol Rep; 2019 Jul; 42(1):202-212. PubMed ID: 31115563
[TBL] [Abstract][Full Text] [Related]
20. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
